My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group.

    [No authors listed]

    Breast Cancer Res. 1999;1(1):73-80. Epub 1999 Aug 19.PMID: 11056681 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Breast cancer and hormone-replacement therapy in the Million Women Study.

    Beral V; Million Women Study Collaborators.

    Lancet. 2003 Aug 9;362(9382):419-27. Erratum in: Lancet. 2003 Oct 4;362(9390):1160. PMID: 12927427 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.

    Reeves GK, Beral V, Green J, Gathani T, Bull D; Million Women Study Collaborators.

    Lancet Oncol. 2006 Nov;7(11):910-8.PMID: 17081916 [PubMed - indexed for MEDLINE]Related articles

    4.

    Estrogen replacement therapy in patients with early breast cancer.

    Natrajan PK, Gambrell RD Jr.

    Am J Obstet Gynecol. 2002 Aug;187(2):289-94; discussion 294-5.PMID: 12193914 [PubMed - indexed for MEDLINE]Related articles

    5.

    Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme.

    Gathani T, Bull D, Green J, Reeves G, Beral V; Million Women Study Collaborators.

    Breast Cancer Res. 2005;7(6):R1090-6. Epub 2005 Nov 9.PMID: 16457689 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.

    Dimitrakakis C, Jones RA, Liu A, Bondy CA.

    Menopause. 2004 Sep-Oct;11(5):531-5.PMID: 15356405 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ovarian cancer and hormone replacement therapy in the Million Women Study.

    Beral V; Million Women Study Collaborators, Bull D, Green J, Reeves G.

    Lancet. 2007 May 19;369(9574):1703-10.PMID: 17512855 [PubMed - indexed for MEDLINE]Related articles

    8.

    Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study.

    Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, Briers P, English R, Jackson A, Kutt E, Lavelle J, Rockall L, Wallis MG, Wilson M, Patnick J.

    BMJ. 2004 Aug 28;329(7464):477.PMID: 15331472 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

    Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ.

    JAMA. 2001 Mar 21;285(11):1460-5.PMID: 11255422 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.

    Gwinn ML.

    J Obstet Gynaecol (Lahore). 1985 Jan;5 Suppl 2:S83-7.PMID: 12268773 [PubMed - indexed for MEDLINE]Related articles

    11.

    Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.

    Hofvind S, Møller B, Thoresen S, Ursin G.

    Int J Cancer. 2006 Jun 15;118(12):3112-7.PMID: 16395702 [PubMed - indexed for MEDLINE]Related articles

    12.

    The Million Women Study: potential biases do not allow uncritical acceptance of the data.

    Shapiro S.

    Climacteric. 2004 Mar;7(1):3-7.PMID: 15259277 [PubMed - indexed for MEDLINE]Related articles

    13.

    Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.

    [No authors listed]

    Prescrire Int. 2004 Jun;13(71):106-9.PMID: 15233153 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hormone therapy and ovarian cancer.

    Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjaer S, Lidegaard O.

    JAMA. 2009 Jul 15;302(3):298-305.PMID: 19602689 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.

    Liu B, Beral V, Balkwill A, Green J, Sweetland S, Reeves G; Million Women Study Collaborators.

    BMJ. 2008 Jul 10;337:a386. doi: 10.1136/bmj.a386.PMID: 18617493 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.

    Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M.

    Int J Cancer. 2007 Aug 1;121(3):645-8.PMID: 17372914 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mammography screening in the county of Fyn. November 1993-December 1999.

    Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W, Lynge E.

    APMIS Suppl. 2003;(110):1-33.PMID: 12739252 [PubMed - indexed for MEDLINE]Related articles

    18.

    Endometrial cancer and hormone-replacement therapy in the Million Women Study.

    Beral V, Bull D, Reeves G; Million Women Study Collaborators.

    Lancet. 2005 Apr 30-May 6;365(9470):1543-51.PMID: 15866308 [PubMed - indexed for MEDLINE]Related articles

    19.

    Screening for breast cancer in England: past and future.

    Advisory Committee on Breast Cancer Screening.

    J Med Screen. 2006;13(2):59-61.PMID: 16792825 [PubMed - indexed for MEDLINE]Related articles

    20.

    The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.

    Lemay A.

    J Obstet Gynaecol Can. 2002 Sep;24(9):711-5.PMID: 12360366 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk